Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bailing Capsule dose-comparison study in chronic kidney disease
ChiCTR-IPD-17013330Phase 4Recruiting
- Sponsor
- Longhua Hospital Shanghai University of Traditional Chinese Medicine
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bailing jiaonang in chronic kidney disease (CKD) (2 arms), sponsored by Longhua Hospital Shanghai University of Traditional Chinese Medicine. Primary endpoints: Glomerular filtration rate and 24-hour urine protein quantitation. Started Jun 2017; status: recruiting.
02
Drugs
bailing jiaonang
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR-IPD-17013330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPD-17013330.